Jubilant Pharmova Financials
NSE: JUBLPHARMA | BSE: 530019
₹907.90
₹7.60
(0.84%)
As on 03-Sep-2026 15:54IST
Market cap
₹14,436 Cr
Revenue (TTM)
₹8,608 Cr
P/E Ratio
41
P/B Ratio
2
Div. Yield
0.6 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
8,608.30
|
8,279.60
|
7,234.50
|
6,702.90
|
6,281.70
|
6,130.16
|
|
|
|
|
|
|
Total Income
|
8,682.20
|
8,345.60
|
7,291.30
|
6,771.60
|
6,320.00
|
6,141.45
|
|
|
|
|
|
|
Total Expenditure
|
7,390.10
|
7,019.80
|
6,060.80
|
5,802.10
|
5,505.50
|
4,973.83
|
|
|
|
|
|
|
EBITDA
|
1,218.20
|
1,259.80
|
1,173.70
|
900.80
|
776.20
|
1,156.33
|
|
|
|
|
|
|
Depreciation
|
469.60
|
440.40
|
368.60
|
381.90
|
554.00
|
381.70
|
|
|
|
|
|
|
EBIT
|
748.60
|
819.40
|
805.10
|
518.90
|
222.20
|
774.63
|
|
|
|
|
|
|
Interest
|
217.00
|
211.80
|
240.30
|
272.30
|
188.20
|
145.49
|
|
|
|
|
|
|
Other Income
|
73.90
|
66.00
|
56.80
|
68.70
|
38.30
|
11.29
|
|
|
|
|
|
|
Exceptional Items
|
-59.20
|
-59.20
|
359.50
|
-168.90
|
-56.80
|
--
|
|
|
|
|
|
|
Profit before Tax
|
546.30
|
614.10
|
980.60
|
170.50
|
27.80
|
630.45
|
|
|
|
|
|
|
Provision for Tax
|
194.70
|
216.60
|
144.30
|
97.80
|
92.70
|
217.43
|
|
|
|
|
|
|
Profit after Tax
|
351.60
|
397.50
|
836.30
|
72.70
|
-64.90
|
413.02
|
|
|
|
|
|
|
Minority Interest
|
0.70
|
1.00
|
3.10
|
4.40
|
3.90
|
0.92
|
|
|
|
|
|
|
Share of Associate
|
-0.20
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
352.10
|
398.50
|
839.40
|
77.10
|
-61.00
|
413.94
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
7,092.80
|
7,092.80
|
6,255.00
|
5,433.90
|
5,399.30
|
5,318.56
|
|
|
|
|
|
|
Minority Interest
|
0.70
|
2.80
|
-16.30
|
-12.80
|
-7.50
|
-2.16
|
|
|
|
|
|
|
Non-Current Liabilities
|
5,888.20
|
5,631.10
|
4,095.80
|
4,005.70
|
3,765.00
|
2,921.60
|
|
|
|
|
|
|
Current Liabilities
|
2,538.90
|
2,538.90
|
2,164.60
|
1,889.00
|
1,772.40
|
1,591.60
|
|
|
|
|
|
|
Total Liabilities
|
15,522.70
|
15,272.00
|
12,584.30
|
11,337.70
|
10,929.20
|
9,829.60
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
10,892.60
|
11,156.30
|
8,921.80
|
7,439.70
|
7,166.80
|
6,320.40
|
|
|
|
|
|
|
Current Assets
|
4,109.30
|
4,109.30
|
3,509.80
|
3,632.20
|
3,762.40
|
3,509.19
|
|
|
|
|
|
|
Total Assets
|
15,522.70
|
15,272.00
|
12,584.30
|
11,337.70
|
10,929.20
|
9,829.60
|
|
|
|
|
|
|
Total Debt*
|
--
|
3,219.50
|
2,436.90
|
3,414.10
|
3,410.10
|
2,927.62
|
|
|
|
|
|
|
Net Current Assets
|
1,570.40
|
1,570.40
|
1,345.20
|
1,743.20
|
1,990.00
|
1,917.59
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
419.40
|
368.40
|
456.20
|
402.30
|
420.31
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
1,226.80
|
1,072.10
|
971.30
|
660.70
|
837.54
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-1,260.00
|
487.70
|
-607.90
|
-544.40
|
-380.37
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
94.90
|
-1,452.70
|
-432.50
|
-156.70
|
-32.60
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
61.70
|
107.10
|
-69.10
|
-40.40
|
424.57
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
24.41
|
25.22
|
53.13
|
4.88
|
-3.84
|
26.01
|
|
|
|
|
|
|
Cash EPS (₹)
|
22.11
|
53.03
|
76.26
|
28.77
|
30.76
|
49.93
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
447.64
|
447.70
|
394.94
|
343.00
|
339.19
|
333.91
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.55
|
5.00
|
5.00
|
5.00
|
5.00
|
5.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
77.65
|
67.85
|
61.47
|
41.55
|
52.62
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-29.86
|
12.73
|
-12.03
|
-17.05
|
1.03
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
8.69
|
13.92
|
5.02
|
2.53
|
9.97
|
|
|
|
|
|
|
ROE (%)
|
5.68
|
5.97
|
14.35
|
1.34
|
-1.21
|
8.21
|
|
|
|
|
|
|
ROA (%)
|
2.49
|
2.86
|
7.02
|
0.65
|
-0.63
|
4.44
|
|
|
|
|
|
|
EBIT Margin (%)
|
8.70
|
9.90
|
11.13
|
7.74
|
3.54
|
12.64
|
|
|
|
|
|
|
Net Margin (%)
|
4.05
|
4.76
|
11.47
|
1.07
|
-1.03
|
6.73
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
9.58
|
15.76
|
6.78
|
7.79
|
12.96
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
16.27
|
14.45
|
7.93
|
6.71
|
2.47
|
0.52
|
|
|
|
|
|
|
EBIT Growth (%)
|
-10.43
|
1.78
|
55.16
|
133.53
|
-71.32
|
-26.05
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-20.22
|
-52.47
|
1,050.34
|
212.02
|
-115.71
|
-28.03
|
|
|
|
|
|
|
EPS Growth (%)
|
-23.49
|
-52.53
|
988.73
|
227.19
|
-114.75
|
-50.48
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
13.36
|
15.14
|
0.49
|
1.47
|
12.11
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
41.00
|
32.37
|
16.80
|
116.50
|
--
|
14.91
|
|
|
|
|
|
|
Price / Book Value
|
2.02
|
1.82
|
2.26
|
1.66
|
0.82
|
1.16
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.55
|
0.61
|
0.56
|
0.88
|
1.79
|
1.29
|
|
|
|
|
|
|
EV/EBITDA
|
12.68
|
11.20
|
12.56
|
11.80
|
8.39
|
6.95
|
|
|
|
|
|
|
Close Price (₹)
|
970.90
|
816.45
|
895.90
|
569.90
|
278.85
|
388.15
|
|
|
|
|
|
|
High Price (₹)
|
1,250.00
|
1,250.00
|
1,309.90
|
627.45
|
495.95
|
925.00
|
|
|
|
|
|
|
Low Price (₹)
|
783.75
|
783.75
|
566.00
|
268.80
|
268.80
|
384.85
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
14,436.45
|
12,899.62
|
14,104.38
|
8,982.56
|
4,436.76
|
6,172.62
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.42
|
0.46
|
0.39
|
0.63
|
0.63
|
0.55
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.02
|
0.04
|
0.04
|
0.05
|
0.01
|
|
|
|
|
|
|
Current Ratio
|
1.62
|
1.62
|
1.62
|
1.92
|
2.12
|
2.20
|
|
|
|
|
|
|
Quick Ratio
|
1.13
|
1.13
|
1.10
|
1.24
|
1.34
|
1.42
|
|
|
|
|
|
|
Interest Coverage
|
3.52
|
3.90
|
5.08
|
1.63
|
1.15
|
5.33
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
12.43
|
12.92
|
12.32
|
13.66
|
15.30
|
15.14
|
|
|
|
|
|
|
Asset Turnover
|
0.61
|
0.63
|
0.64
|
0.60
|
0.61
|
0.66
|
|
|
|
|
|
|
Receivable days
|
--
|
40.92
|
43.15
|
51.11
|
54.89
|
52.04
|
|
|
|
|
|
|
Inventory Days
|
--
|
49.26
|
57.75
|
72.70
|
76.56
|
70.98
|
|
|
|
|
|
|
Payable days
|
--
|
154.52
|
146.59
|
143.02
|
134.99
|
133.47
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-64.33
|
-45.69
|
-19.21
|
-3.54
|
-10.45
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
